Decision-Aiding System Improves Clinical Trial Performance
The CCI-CPP collaborative team announces the newest release of Country Allocation Planner? (CAP), a Web-based system for global clinical trial planning.??
DECISION-AIDING SYSTEM IMPROVES CLINICAL TRIAL PERFORMANCE
ATLANTA, GA June 19, 2008 – The CCI-CPP collaborative team announces the newest release of Country Allocation Planner™ (CAP), a Web-based system for global clinical trial planning. CAP improves clinical trial enrollment forecasting and the process of selecting countries for study participation by facilitating robust, unlimited and real-time “what if” scenario modeling.
“Fundamentally, CAP helps study planning teams forecast realistic enrollment times and select the optimum mix of countries and subject contributions to meet key operational objectives, like cycle time and cost,” says Beth Harper of Clinical Performance Partners, Inc.
The design for the system is a result of a collaborative effort between Core Concept, Inc., specialists in software, simulation and decision support, and Clinical Performance Partners, Inc. a provider of enrollment and site performance management services. CAP uses industry data on disease prevalence as well as internal company benchmark data, and then incorporates enrollment feasibility data to plan, manage and update enrollment projections.
CAP’s linear programming and advanced data modeling capabilities allow planning across multiple parameters, such as number of countries and investigative sites, enrollment rate, subject contribution, disease prevalence, and per subject cost. This breadth of enrollment planning is generally not feasible for most users engaged in global clinical trials.
“Our user-friendly system ensures that all available information and advanced analysis techniques are combined to provide the sponsor or contract research organization (CRO) with insight into the best possible scenarios for enrollment success,” states Rob Andes, Executive Vice President of Core Concept. CAP does not make decisions, rely on team assumptions to make arbitrary enrollment projections or force the user to adhere to a set workflow.
Want to learn more or schedule a demo? Contact Rob Andes at 678/772-7181 or email [email protected].
About Clinical Performance Partners - CPP is a consulting firm dedicated to designing and implementing innovative and practical solutions for improving site performance and accelerating clinical trials results for the Life Sciences Industry. www.clinicalperformancepartners.com
About Core Concept, Inc. – CCI is a software product company specializing in the development of advanced decision support systems for the analysis, forecasting, planning and management of clinical trials and payor management. www.coreconcept.com
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
